Cat /

Breed profile · FDA CVM July 2026 extract

Abyssinian cat adverse-event record

Adverse-event filings for Abyssinian cat (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.

Verify with FDA CVM →
#185 of 510
by report volume (all breeds)
201
FDA CVM reports on file
9.5%
death-coded share of reports
#55 of 275
by death-coded share (≥50 reports)

How the 201 reports break down

By recorded gender -- every report on file for Abyssinian cat, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 20 15 10 5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Abyssinian cat drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Abyssinian cat ranks #185 of 510 by total reports (201) and #55 of 275 by death-coded share (9.5%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#185
This breed, reports of 510
#55
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Abyssinian cat has 201 reports now versus 199 in that prior snapshot: 2 more (1.0%).

Report change
+2
Death-coded reports
+0
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Abyssinian cat changes

Total Reports

201

Above-median volume

Deaths Reported

19

of 201 reports

Death-coded share of reports

9.5%

High death-coded share

Avg Age at Report

7.6 yr

4.2 kg avg weight

Breed Safety Scorecard

F (12/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate F
9.5%

Share of reports coded as a fatality

Euthanasia rate F
5.5%

Share of reports resulting in euthanasia

Full recovery rate F
21.9%

Share of reports coded "Recovered/Normal"

5-year trend F
+113%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Abyssinian cat death-coded reports 9.5%
Cross-breed median

9.5% of 201 abyssinian cat reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Abyssinian cat's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

9% 80th percentile Higher share than 80% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Abyssinian cat 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 4.2 kg (9.3 lbs)

Top Reported Reactions

Anorexia 24
Vomiting 23
Lethargy (see also Central nervous system depression in 'Neurological') 21
Other abnormal test result NOS 17
Application site alopecia 15
Weight loss 14
Ataxia 14
Lack of efficacy - NOS 14

Most Referenced Drugs

Selamectin 26
Robenacoxib 21
Frunevetmab 20
Spinosad 16
Buprenorphine 16
Cefovecin 15
Maropitant Citrate 11
Emodepside + Praziquantel 9

Outcome Breakdown

Ongoing
70 (37.6%)
Outcome Unknown
49 (26.3%)
Recovered/Normal
44 (23.7%)
Euthanized
11 (5.9%)
Died
9 (4.8%)
Recovered with Sequela
3 (1.6%)

Gender Distribution

Female 101 (50.2%)
Male 97 (48.3%)
Unknown 2 (1.0%)
Mixed 1 (0.5%)

Reports by Year

Year Reports Trend
2010 10
2011 9
2012 15
2013 21
2014 4
2015 15
2016 10
2017 12
2018 12
2019 10
2020 9
2021 8
2022 7
2023 20
2024 20
2025 17
2026 2

Abyssinian cat: high death-coded share in the FDA CVM extract

Signature read: Abyssinian cat's 9.5% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Abyssinian cat sits at #185 of 510 by report volume among all breeds and #19 of 55 among cat breeds, with 201 reports and 19 (9.5%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #55 of 275. Mean age at report: 7.6 years, average weight 4.2 kg (9.3 lbs).

Top reported signs: Anorexia (24), Vomiting (23), Lethargy (see also Central nervous system depression in 'Neurological') (21). Most-referenced drug: Selamectin (26 reports), followed by Robenacoxib (21) and Frunevetmab (20).

Outcome coding on 186 status-recorded reports is dominated by Ongoing (37.6%). Annual submissions ranged 2-2,026 across 17 years on file.

Cat Breeds With a Similar Report Volume

Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.

Norwegian Forest
193 reports · 5.7% death-coded
Sphynx
184 reports · 13.6% death-coded
American Curl Shorthair
228 reports · 3.5% death-coded
Burmese
158 reports · 11.4% death-coded
Manx
284 reports · 11.3% death-coded
Siberian
118 reports · 4.2% death-coded

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Abyssinian cat, both outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (9.5% death-coded here).

Arab 9.6% · Horse Horse (other) 9.8% · Horse Bulldog - English 9.1% · Dog Mastiff (unspecified) 9.8% · Dog

Similar average weight

Nearest other-species breeds by reported average weight (4.2 kg here).

Terrier - Yorkshire 4.2 kg · Dog New Zealand White 4.3 kg · Rabbit Flemish Giant 4.1 kg · Rabbit Turkey (other) 4.0 kg · Turkey

What to do with this cat

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Abyssinian cat? ▼
There are 201 adverse event reports involving Abyssinian cat in the FDA database, of which 19 were death-coded (9.5% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Abyssinian cat ranks #185 of 510 by report volume among all breeds PlainBreed indexes (#19 of 55 among cat breeds).
Where does Abyssinian cat sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Abyssinian cat is #185 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Cat, it is #19 of 55. Among breeds with at least 50 reports, its death-coded share ranks #55 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Abyssinian cat? ▼
The most commonly reported adverse reactions for Abyssinian cat are Anorexia (24 reports), Vomiting (23 reports), Lethargy (see also Central nervous system depression in 'Neurological') (21 reports), Other abnormal test result NOS (17 reports), Application site alopecia (15 reports).
What drugs are most frequently associated with Abyssinian cat adverse events? ▼
The drugs most frequently referenced in Abyssinian cat adverse event reports are Selamectin (26 reports), Robenacoxib (21 reports), Frunevetmab (20 reports), Spinosad (16 reports), Buprenorphine (16 reports).
What is the average age of Abyssinian cat in adverse event reports? ▼
The average age of Abyssinian cat at the time of adverse event reports is 7.6 years, with an average weight of 4.2 kg (9.3 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Abyssinian cat (Cat), extract as of July 2026 extract. 201 reports · 19 death-coded (9.5% of reports, not a mortality rate) · #185 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →